Clinical Trials · NCT02559206

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Name: Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Linaclotide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Ironwood Pharmaceuticals, Inc.
Enrollment: 759
Start date: Oct 2015
Locations: 71 sites, United States
Primary endpoint: Change From Baseline in Weekly Abdominal Pain Score Over the 12-Week Treatment Period: DR1 or IR vs. Placebo

View Linaclotide compound reference